We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Danakali Limited | LSE:DNK | London | Ordinary Share | AU000000DNK9 | ORDS NPV |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 20.00 | 19.00 | 21.00 | 0.00 | 00:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMDNK
RNS Number : 9264T
Danakali Limited
26 March 2019
Rule 2.7, 3.10.3, 3.10.4, 3.10.5
Appendix 3B
New issue announcement,
application for quotation of additional securities
and agreement
Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX's property and may be made public.
Introduced 01/07/96 Origin: Appendix 5 Amended 01/07/98, 01/09/99, 01/07/00, 30/09/01, 11/03/02, 01/01/03, 24/10/05, 01/08/12, 04/03/13
Name of entity DANAKALI LTD ABN 56 097 904 302
We (the entity) give ASX the following information.
Part 1 -- All issues
You must complete the relevant sections (attach sheets if there is not enough space).
1 +Class of +securities Unlisted Options issued or to be issued Number of +securities issued or to be issued (if known) or maximum number which may be 2 issued 583,000 3 Principal terms of Unlisted Options exercisable the +securities (e.g. at $1.108 expiring 13 March if options, exercise 2022 (subject to vesting conditions) price and expiry date; if partly paid +securities, the amount outstanding and due dates for payment; if +convertible securities, the conversion price and dates for conversion) 4 Do the +securities Unlisted Options will rank rank equally in all equally respects from the if converted or exercised into +issue date with an ordinary shares existing +class of quoted +securities? If the additional +securities do not rank equally, please state: * the date from which they do * the extent to which they participate for the next dividend, (in the case of a trust, distribution) or interest payment * the extent to which they do not rank equally, other than in relation to the next dividend, distribution or interest payment 5 Issue price or consideration Nil 6 Purpose of the issue Unlisted Options were issued (If issued as consideration to employees as part of remuneration for the acquisition of assets, clearly identify those assets) 6a Is the entity an +eligible Yes entity that has obtained security holder approval under rule 7.1A? If Yes, complete sections 6b - 6h in relation to the +securities the subject of this Appendix 3B, and comply with section 6i 6b The date the security 11 May 2018 holder resolution under rule 7.1A was passed Number of +securities issued without security holder approval under 6c rule 7.1 583,000 6d Number of +securities Nil issued with security holder approval under rule 7.1A 6e Number of +securities N/A issued with security holder approval under rule 7.3, or another specific security holder approval (specify date of meeting) 6f Number of +securities N/A issued under an exception in rule 7.2 6g If +securities issued N/A under rule 7.1A, was issue price at least 75% of 15 day VWAP as calculated under rule 7.1A.3? Include the +issue date and both values. Include the source of the VWAP calculation. 6h If +securities were N/A issued under rule 7.1A for non-cash consideration, state date on which valuation of consideration was released to ASX Market Announcements 6i Calculate the entity's Capacity under L.R.7.1 is 36,937,032 remaining issue capacity Capacity under LR7.1A is 26,405,778 under rule 7.1 and rule 7.1A - complete Annexure 1 and release to ASX Market Announcements 7 +Issue dates 26 March 2019 Note: The issue date may be prescribed by ASX (refer to the definition of issue date in rule 19.12). For example, the issue date for a pro rata entitlement issue must comply with the applicable timetable in Appendix 7A. Cross reference: item 33 of Appendix 3B. Number +Class Number and +class of all +securities quoted on ASX (including the +securities in 8 section 2 if applicable) 264,422,398 Ordinary Shares --------------------------------- Number +Class 9 Number and +class of all +securities 400,000 Unlisted Options not quoted on ASX exercisable (including the +securities at $0.96 each, in section 2 if applicable) 900,000 expiring 20 June 2019 Unlisted Options 250,000 exercisable at $0.558 each, expiring 8 August 2019 1,440,000 (Remuneration Options) Unlisted Options 1,724,015 exercisable at $0.543 each, expiring 7 October 2019 583,000 (Remuneration Options) Unlisted Options 280,000 exercisable at $0.94 each, 800,000 expiring 19 May 2020 100,000 (Remuneration Options) 40,000 Unlisted Options 30,000 exercisable at $1.031 each, 65,000 expiring
24 January 2022 (Remuneration Options) Unlisted Options exercisable at $1.031 each, expiring 24 January 2022 (Remuneration Options) Performance Rights - Class 1 Performance Rights - Class 4 Performance Rights - Class 5 Performance Rights - Class 6 Performance Rights - Class 7 Performance Rights - Class 8 ----------------------------------- 10 Dividend policy (in N/A the case of a trust, distribution policy) on the increased capital (interests)
Part 2 -- Pro rata issue
11 Is security holder approval N/A required? 12 Is the issue renounceable N/A or non-renounceable? 13 Ratio in which the +securities N/A will be offered 14 +Class of +securities N/A to which the offer relates 15 +Record date to determine N/A entitlements 16 Will holdings on different N/A registers (or subregisters) be aggregated for calculating entitlements? 17 Policy for deciding entitlements N/A in relation to fractions 18 Names of countries in N/A which the entity has security holders who will not be sent new offer documents Note: Security holders must be told how their entitlements are to be dealt with. Cross reference: rule 7.7. 19 Closing date for receipt N/A of acceptances or renunciations 20 Names of any underwriters N/A 21 Amount of any underwriting N/A fee or commission 22 Names of any brokers to N/A the issue 23 Fee or commission payable N/A to the broker to the issue 24 Amount of any handling N/A fee payable to brokers who lodge acceptances or renunciations on behalf of security holders 25 If the issue is contingent N/A on security holders' approval, the date of the meeting 26 Date entitlement and acceptance N/A form and offer documents will be sent to persons entitled 27 If the entity has issued N/A options, and the terms entitle option holders to participate on exercise, the date on which notices will be sent to option holders 28 Date rights trading will N/A begin (if applicable) ----------------- 29 Date rights trading will N/A end (if applicable) 30 How do security holders N/A sell their entitlements in full through a broker? 31 How do security holders N/A sell part of their entitlements through a broker and accept for the balance? 32 How do security holders N/A dispose of their entitlements (except by sale through a broker)? 33 +Issue date N/A
Part 3 -- Quotation of securities
You need only complete this section if you are applying for quotation of securities
34 Type of +securities (tick one) (a) X +Securities described in Part 1 (b) All other +securities Example: restricted securities at the end of the escrowed period, partly paid securities that become fully paid, employee incentive share securities when restriction ends, securities issued on expiry or conversion of convertible securities
Entities that have ticked box 34(a)
Additional securities forming a new class of securities
Tick to indicate you are providing the information or documents 35 If the +securities are +equity securities, the names of the 20 largest holders of the additional +securities, and the number and percentage of additional +securities held by those holders 36 If the +securities are +equity securities, a distribution schedule of the additional +securities setting out the number of holders in the categories 1 - 1,000 1,001 - 5,000 5,001 - 10,000 10,001 - 100,000 100,001 and over 37 A copy of any trust deed for the additional +securities
Entities that have ticked box 34(b)
38 Number of +securities N/A for which +quotation is sought 39 +Class of +securities N/A for which quotation is sought 40 Do the +securities N/A rank equally in all respects from the +issue date with an existing +class of quoted +securities? If the additional +securities do not rank equally, please state: * the date from which they do * the extent to which they participate for the next dividend, (in the case of a trust, distribution) or interest payment * the extent to which they do not rank equally, other than in relation to the next dividend, distribution or interest payment 41 Reason for request N/A for quotation now Example: In the case of restricted securities, end of restriction period (if issued upon conversion of another +security, clearly identify that other +security) Number +Class
42 Number and +class of N/A N/A all +securities quoted on ASX (including the +securities in clause 38) ---------
Quotation agreement
1 +Quotation of our additional +securities are in ASX's absolute discretion. ASX may quote the +securities on any conditions it decides.
2 We warrant the following to ASX.
-- The issue of the +securities to be quoted complies with the law and is not for an illegal purpose.
-- There is no reason why those +securities should not be granted +quotation.
-- An offer of the (+) securities for sale within 12 months after their issue will not require disclosure under section 707(3) or section 1012C(6) of the Corporations Act.
Note: An entity may need to obtain appropriate warranties from subscribers for the securities in order to be able to give this warranty
-- Section 724 or section 1016E of the Corporations Act does not apply to any applications received by us in relation to any +securities to be quoted and that no-one has any right to return any +securities to be quoted under sections 737, 738 or 1016F of the Corporations Act at the time that we request that the +securities be quoted.
-- If we are a trust, we warrant that no person has the right to return the +securities to be quoted under section 1019B of the Corporations Act at the time that we request that the +securities be quoted.
3 We will indemnify ASX to the fullest extent permitted by law in respect of any claim, action or expense arising from or connected with any breach of the warranties in this agreement.
4 We give ASX the information and documents required by this form. If any information or document is not available now, we will give it to ASX before +quotation of the +securities begins. We acknowledge that ASX is relying on the information and documents. We warrant that they are (will be) true and complete.
26 March 2019
Sign here: ............................................................ Date: .........................
(Director/Company secretary)
Catherine Grant-Edwards
Print name: .........................................................
== == == == ==
Appendix 3B - Annexure 1
Calculation of placement capacity under rule 7.1 and rule 7.1A for (+) eligible entities
Introduced 01/08/12
Part 1
Rule 7.1 - Issues exceeding 15% of capital Step 1: Calculate "A", the base figure from which the placement capacity is calculated Insert number of fully paid ordinary securities on issue 12 months before date of issue or agreement to issue 259,379,506 ----------------------------------------------------------------------------- Add the following: 125,000 (fully paid ordinary shares * Number of fully paid ordinary securities issued in issued 29 March 2018 on exercise of that 12 month period under an exception in rule 7.2 options) 727,274 (fully paid ordinary shares issued 29 March 2018 on exercise of * Number of fully paid ordinary securities issued in options) that 12 month period with shareholder approval 2,272,728 (fully paid ordinary shares issued 4 April 2018 on exercise of options) 738,346 (fully paid ordinary shares * Number of partly paid ordinary securities that became issued 14 May 2018 on cashless exercise fully paid in that 12 month period of options) 116,586 (fully paid ordinary shares issued 29 May 2018 on cashless exercise Note: of options) * Include only ordinary securities here - other classes 90,740 (fully paid ordinary shares issued of equity securities cannot be added 31 May 2018 on cashless exercise of options) 151,234 (fully paid ordinary shares * Include here (if applicable) the securities the issued 31 May 2018 on cashless exercise subject of the Appendix 3B to which this form is of options) annexed 200,000 (fully paid ordinary shares issued 14 June 2018 on exercise of options) 10,000 (fully paid ordinary shares issued * It may be useful to set out issues of securities on 14 June 2018 on vesting of Class 7 performance different dates as separate line items rights) 10,000 (fully paid ordinary shares issued 26 July 2018 on vesting of Class 6 performance rights) 20,000 (fully paid ordinary shares issued 26 July 2018 on vesting of Class 8 performance rights) 216,364 (fully paid ordinary shares issued 7 November 2018 on cashless exercise of options) ----------------------------------------------------------------------------- Subtract the number of fully N/A paid ordinary securities cancelled during that 12 month period ----------------------------------------------------------------------------- "A" 264,057,778 ----------------------------------------------------------------------------- Step 2: Calculate 15% of "A" "B" 0.15 [Note: this value cannot be changed] --------------------------------------------------------------- Multiply "A" by 0.15 39,608,667 --------------------------------------------------------------- Step 3: Calculate "C", the amount of placement capacity under rule 7.1 that has already been used Insert number of equity securities 356,049 fully paid ordinary issued or agreed to be issued shares (24 July 2018) in that 12 month period not 8,571 fully paid ordinary shares counting those issued: (20 December 2018) * Under an exception in rule 7.2 1,724,015 unlisted options (27 February 2019) 583,000 unlisted options (26
* Under rule 7.1A March 2019) * With security holder approval under rule 7.1 or rule 7.4 Note: * This applies to equity securities, unless specifically excluded - not just ordinary securities * Include here (if applicable ) the securities the subject of the Appendix 3B to which this form is annexed * It may be useful to set out issues of securities on different dates as separate line items --------------------------------------------------------------- "C" 2,671,635 --------------------------------------------------------------- Step 4: Subtract "C" from ["A" x "B"] to calculate remaining placement capacity under rule 7.1 "A" x 0.15 Note: number must be same as shown in Step 2 39,608,667 --------------------------------------------------------------- Subtract "C" Note: number must be same as shown in Step 3 2,671,635 --------------------------------------------------------------- Total ["A" x 0.15] - "C" 36,937,032 ---------------------------------------------------------------
Part 2
Rule 7.1A - Additional placement capacity for eligible entities Step 1: Calculate "A", the base figure from which the placement capacity is calculated "A" Note: number must be same as shown in Step 1 of Part 1 264,057,778 ------------------------------------- Step 2: Calculate 10% of "A" "D" 0.10 Note: this value cannot be changed ------------------------------------- Multiply "A" by 0.10 26,405,778 ------------------------------------- Step 3: Calculate "E", the amount of placement capacity under rule 7.1A that has already been used Insert number of equity securities Nil issued or agreed to be issued in that 12 month period under rule 7.1A Notes: -- This applies to equity securities - not just ordinary securities -- Include here - if applicable - the securities the subject of the Appendix 3B to which this form is annexed -- Do not include equity securities issued under rule 7.1 (they must be dealt with in Part 1), or for which specific security holder approval has been obtained -- It may be useful to set out issues of securities on different dates as separate line items ------------------------------------- "E" Nil ------------------------------------- Step 4: Subtract "E" from ["A" x "D"] to calculate remaining placement capacity under rule 7.1A "A" x 0.10 Note: number must be same as shown in Step 2 26,405,778 ------------------------------------- Subtract "E" Nil Note: number must be same as shown in Step 3 ------------------------------------- Total ["A" x 0.10] - "E" 26,405,778 -------------------------------------
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
END
MSCGMGZFKKZGLZM
(END) Dow Jones Newswires
March 26, 2019 03:00 ET (07:00 GMT)
1 Year Danakali Chart |
1 Month Danakali Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions